Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0034 | 1 |
mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |